Mizuho Securities Remains Bullish on Eagle Pharmaceuticals (EGRX) Despite Weak 4Q; Investors Focus on Bendeka Opportunity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Mizuho Securities Remains Bullish on Eagle Pharmaceuticals (EGRX) Despite Weak 4Q; Investors Focus on Bendeka Opportunity

Eagle Pharmaceuticals (EGRX) Misses Q4 EPS Views

February 25, 2016 6:50 AM EST

Eagle Pharmaceuticals (NASDAQ: EGRX) reported Q4 EPS of $0.07, $0.23 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $18.2 million versus the consensus estimate of $20.78 million.

For earnings history and earnings-related data on Eagle Pharmaceuticals (EGRX) click here.

... More

Trading Radar for 2/25: Baidu (BIDU), Best Buy (BBY), Sears (SHLD), Weight Watchers (WTW) Report

February 24, 2016 2:50 PM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EST

Initial Claims - Street sees 270kContinuing Claims - Street sees 2.268MDurable Orders - Street sees 2.0%

9:00am EST

FHFA Home Price Index - no Street consensus

Earnings:

AB InBev SA (NYSE: BUD) - consensus EPS $1.23
ACI Worldwide, Inc. (Nasdaq: ACIW) - consensus EPS $0.47
AMC Networks (Nasdaq:... More